• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • David Solomon, UK

    David Solomon, UK

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • David Hall, USA

    David Hall, USA

  • Michael Lee, Australia

    Michael Lee, Australia

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Daniel Hare, USA

    Daniel Hare, USA

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Philip Brindle, England

    Philip Brindle, England

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • John Sweeney, USA

    John Sweeney, USA

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Anita Forte, USA

    Anita Forte, USA

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Susan Anderson, USA

    Susan Anderson, USA

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Sally Pauls, USA

    Sally Pauls, USA

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login